| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | OPTOFLUIDIC BIOASSAY LLC | 600 S WAGNER RD | ANN ARBOR | MI | 48103-9002 | WASHTENAW | USA | R43GH002391 | PA21-259, PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical | 03 | 1 | CDC | 2/2/2024 | $0 |
| | 2024 | 2022 | OPTOFLUIDIC BIOASSAY LLC | 600 S WAGNER RD | ANN ARBOR | MI | 48103-9002 | WASHTENAW | USA | R43GH002391 | PA21-259, PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical | 03 | 1 | CDC | 2/2/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $256,131 ) |
| | 2022 | 2022 | OPTOFLUIDIC BIOASSAY, LLC | 674 S Wagner Rd | Ann Arbor | MI | 48103-9002 | WASHTENAW | USA | R43GH002391 | PA21-259, PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical | 02 | 1 | CDC | 8/31/2022 | $256,131 |
| | 2022 | 2022 | OPTOFLUIDIC BIOASSAY, LLC | 674 S Wagner Rd | Ann Arbor | MI | 48103-9002 | WASHTENAW | USA | R43GH002391 | PA21-259, PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical | 01 | 1 | CDC | 8/30/2022 | $0 |
| | 2022 | 2022 | OPTOFLUIDIC BIOASSAY, LLC | 674 S Wagner Rd | Ann Arbor | MI | 48103-9002 | WASHTENAW | USA | R43GH002391 | PA21-259, PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical | 02 | 1 | CDC | 8/31/2022 | -$256,131 |
| | 2022 | 2022 | Optofluidic Bioassay, LLC | 674 S Wagner Rd | Ann Arbor | MI | 48103-9002 | WASHTENAW | USA | R43GH002391 | PA21-259, PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical | 00 | 1 | CDC | 8/10/2022 | $256,131 |
|
|
